Literature DB >> 31373788

Genome Engineering of Eubacterium limosum Using Expanded Genetic Tools and the CRISPR-Cas9 System.

Jongoh Shin1, Seulgi Kang1, Yoseb Song1, Sangrak Jin1, Jin Soo Lee1, Jung-Kul Lee2, Dong Rip Kim3, Sun Chang Kim1,4, Suhyung Cho1, Byung-Kwan Cho1,4.   

Abstract

Eubacterium limosum is one of the important bacteria in C1 feedstock utilization as well as in human gut microbiota. Although E. limosum has recently garnered much attention and investigation on a genome-wide scale, a bottleneck for systematic engineering in E. limosum is the lack of available genetic tools and an efficient genome editing platform. To overcome this limitation, we here report expanded genetic tools and the CRISPR-Cas9 system. We have developed an inducible promoter system that enables implementation of the CRISPR-Cas9 system to precisely manipulate target genes of the Wood-Ljungdahl pathway with 100% efficiency. Furthermore, we exploited the effectiveness of CRISPR interference to reduce the expression of target genes, exhibiting substantial repression of several genes in the Wood-Ljungdahl pathway and fructose-PTS system. These expanded genetic tools and CRISPR-Cas9 system comprise powerful and widely applicable genetic tools to accelerate functional genomic study and genome engineering in E. limosum.

Entities:  

Keywords:  CRISPR interference; CRISPR-Cas9; Eubacterium limosum; Wood-Ljungdahl pathway; acetogen; inducible promoter

Mesh:

Substances:

Year:  2019        PMID: 31373788     DOI: 10.1021/acssynbio.9b00150

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  9 in total

1.  Expanding the genetic engineering toolbox for the metabolically flexible acetogen Eubacterium limosum.

Authors:  Patrick A Sanford; Benjamin M Woolston
Journal:  J Ind Microbiol Biotechnol       Date:  2022-10-13       Impact factor: 4.258

Review 2.  CRISPR-Based Approaches for Gene Regulation in Non-Model Bacteria.

Authors:  Stephanie N Call; Lauren B Andrews
Journal:  Front Genome Ed       Date:  2022-06-23

Review 3.  Reprogramming Microbial CO2-Metabolizing Chassis With CRISPR-Cas Systems.

Authors:  Hai-Yan Yu; Shu-Guang Wang; Peng-Fei Xia
Journal:  Front Bioeng Biotechnol       Date:  2022-06-23

Review 4.  Engineering Acetogenic Bacteria for Efficient One-Carbon Utilization.

Authors:  Hyeonsik Lee; Jiyun Bae; Sangrak Jin; Seulgi Kang; Byung-Kwan Cho
Journal:  Front Microbiol       Date:  2022-05-09       Impact factor: 6.064

5.  SynBioStrainFinder: A microbial strain database of manually curated CRISPR/Cas genetic manipulation system information for biomanufacturing.

Authors:  Pengli Cai; Mengying Han; Rui Zhang; Shaozhen Ding; Dachuan Zhang; Dongliang Liu; Sheng Liu; Qian-Nan Hu
Journal:  Microb Cell Fact       Date:  2022-05-14       Impact factor: 6.352

6.  Production of the biocommodities butanol and acetone from methanol with fluorescent FAST-tagged proteins using metabolically engineered strains of Eubacterium limosum.

Authors:  Maximilian Flaiz; Gideon Ludwig; Frank R Bengelsdorf; Peter Dürre
Journal:  Biotechnol Biofuels       Date:  2021-05-10       Impact factor: 6.040

7.  Design, Analysis, and Implementation of a Novel Biochemical Pathway for Ethylene Glycol Production in Clostridium autoethanogenum.

Authors:  Barbara Bourgade; Christopher M Humphreys; James Millard; Nigel P Minton; M Ahsanul Islam
Journal:  ACS Synth Biol       Date:  2022-05-11       Impact factor: 5.249

Review 8.  Synthetic Biology on Acetogenic Bacteria for Highly Efficient Conversion of C1 Gases to Biochemicals.

Authors:  Sangrak Jin; Jiyun Bae; Yoseb Song; Nicole Pearcy; Jongoh Shin; Seulgi Kang; Nigel P Minton; Philippe Soucaille; Byung-Kwan Cho
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

9.  High methanol-to-formate ratios induce butanol production in Eubacterium limosum.

Authors:  Jamin C Wood; Esteban Marcellin; Manuel R Plan; Bernardino Virdis
Journal:  Microb Biotechnol       Date:  2021-11-28       Impact factor: 6.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.